Profusa's Q1 Net Loss Widens to $(3.46M), Dwarfing Market Cap Amid Financial Distress
PFSA is trading near its 52-week low of $0.403 (13% above the low).
Summary
Profusa, Inc. reported a first-quarter 2026 net loss of $(3.46M) and diluted loss per share of $(2.05), marking a significant 27% widening of losses year-over-year. This substantial loss, which exceeds the company's current market capitalization, underscores severe cash burn and financial instability. The Q1 results reinforce the dire financial narrative established by the recent 10-K, which highlighted dramatic net losses and a going concern warning. This comes amidst a series of concerning events, including a proposed second reverse stock split, highly dilutive financing, and a recent transfer to the Nasdaq Capital Market, all indicative of a company in deep distress. Traders will view these results as critical confirmation of the company's precarious financial position, despite ongoing product development efforts. Investors should closely monitor the outcome of the strategic alternatives review and any further capital raises.
At the time of this announcement, PFSA was trading at $0.45 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2M. The 52-week trading range was $0.40 to $975.00. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.